KDventures ABLTS:0P3C 38 PS Ratio is 66.88 as of Jul. 12, 2026, which is 57% below its 10-year median of 155.75. GuruFocus rates LTS:0P3C with a GF Score™ of 38/100 and a GF Value™ of kr0.77 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 930 Biotechnology companies, KDventures AB ranks worse than 81.18% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, KDventures AB's share price is kr0.2675.
KDventures AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.00. Hence, KDventures AB's PS Ratio for today is 66.88.
The historical rank and industry rank for KDventures AB's PS Ratio or its related term are showing as below:
LTS:0P3C'
s PS Ratio Range Over the Past 10 Years
Min: 45.6 Med: 155.75 Max: 560.92
Current: 64.63
During the past 13 years, KDventures AB's highest PS Ratio was 560.92. The lowest was 45.60. And the median was 155.75.
LTS:0P3C's PS Ratio is ranked worse than 81.18% of 930
companies
in the Biotechnology industry
Industry Median: 9.51
vs LTS:0P3C: 64.63
KDventures AB revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of KDventures AB was -20.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -10.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -14.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -23.50% per year.
During the past 13 years, KDventures AB's highest 3-Year average Revenue per Share Growth Rate was 36.30% per year. The lowest was -43.30% per year. And the median was -24.20% per year.
Back to Basics: PS Ratio
KDventures AB (LTS:0P3C) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
KDventures AB PS Ratio Related Terms
KDventures AB PS Ratio Historical Data
* Premium members only.
The historical data trend for KDventures AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, KDventures AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where KDventures AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
KDventures AB's Share Price of today is kr0.2675. KDventures AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
KDventures AB (LTS:0P3C) has a PS Ratio of 66.88 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on KDventures AB and its competitors. This is 57% below median its historical median of 155.75. Over the past decade, KDventures AB's PS Ratio has ranged from 45.60 to 560.92. According to the industry distribution chart, KDventures AB ranks #755 out of 930 companies in the Biotechnology industry, placing it in the top 81.2%.
Is KDventures AB's PS Ratio too high?
KDventures AB's current PS Ratio of 66.88 is 57% below median its 10-year median of 155.75. Over the past 10 years, this metric has ranged from a low of 45.60 to a high of 560.92. The Biotechnology industry median PS Ratio is 9.51. KDventures AB's value of 66.88 is 603.3% above this industry median. Based on the distribution chart, KDventures AB ranks #755 out of 930 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, KDventures AB has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #755 out of 930 companies for PS Ratio. This places KDventures AB in the lower half of its industry. The industry median PS Ratio is 9.51. KDventures AB's value of 66.88 is 603.3% above this benchmark. Historically, KDventures AB's own PS Ratio has ranged from 45.60 to 560.92 over the past decade. While the company's 10-year median is 155.75 vs. the industry median of 9.51, KDventures AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.51, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDventures AB's current PS Ratio of 66.88 is 603.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median PS Ratio is 9.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current PS Ratio is 66.88, which is 57% below median its own 10-year median of 155.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
Based on GuruFocus' analysis, KDventures AB (LTS:0P3C) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.77, compared to a current price of kr0.27 — trading 65.3% below its estimated fair value. The current PS Ratio is 66.88, which is 57% below median its 10-year median of 155.75 and 603.3% above the Biotechnology industry median of 9.51. KDventures AB's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For KDventures AB (LTS:0P3C), the current PS Ratio is 66.88 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (LTS:0P3C) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of kr0.27 is trading 65.3% below its estimated GF Value™ of kr0.77.
GuruFocus considers KDventures AB to be Possible Value Trap.
Key valuation signals for LTS:0P3C:
PS Ratio: 66.88 (57% below median its 10-year median of 155.75)
GF Value™: kr0.77 vs. price of kr0.27 (65.3% below fair value)
Industry Position: 603.3% above the Biotechnology median (#755 of 930)
No single metric tells the full story. See the LTS:0P3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
38GF Score
Get the complete analysis for LTS:0P3C
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0P3C has been successfully added to your 
